Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

In the rapidly evolving world of biotechnology and pharmaceuticals, innovation is the key to staying ahead. One of the most ...

Drug-discovery platforms, technologies that analyze drug candidates, are being combined with AI and machine learning to ...

TandemAI announced it has secured a $22 million Series A extension to further develop its drug discovery platform, which combines advanced AI, physics-based computational methods, and wet lab ...

Global Life Science Leader Leverages Online Research Platform to Streamline Access to Its Cutting-Edge Drug Discovery and Development Solutions SAN DIEGO--(BUSINESS WIRE)--Scientist.com, the leading ...

Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...

It's the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten the time it takes to bring cures to patients.

In recent years, the conversation around artificial intelligence (AI) in healthcare has intensified, especially in the realm of drug discovery. Reshma Kewalramani, the CEO of Vertex Pharmaceuticals, ...

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the next five years. Key factors driving this growth include the increasing ...

In this interview, Dr. Malika Bsibsi discusses the role of iPSC models in advancing neuroscience drug discovery, focusing on neurodegeneration, neuroinflammation, and innovative in vitro approaches.